Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETIC Study: Low Dose THC in Acute CRPS
NCT00377468Phase 2Unknown
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in complex regional pain syndrome (CRPS) comparing Delta9-Tetrahydrocannabinol with Placebo (2 arms). Primary endpoint: Incidence of chronic pain at one year assessed with Visual Analogue Scale (VAS) at 1 year. Status: unknown.
02
Drugs
dronabinol
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT00377468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377468.